rs10097570
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001040032.2(C8orf74):c.242-6251T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.158 in 181,272 control chromosomes in the GnomAD database, including 6,989 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.17 ( 6395 hom., cov: 33)
Exomes 𝑓: 0.094 ( 594 hom. )
Consequence
C8orf74
NM_001040032.2 intron
NM_001040032.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.87
Publications
1 publications found
Genes affected
C8orf74 (HGNC:32296): (chromosome 8 open reading frame 74)
RP1L1 (HGNC:15946): (RP1 like 1) This gene encodes a member of the doublecortin family. The protein encoded by this gene contains two N-terminal doublecortin domains, which bind microtubules and regulate microtubule polymerization, and two C-terminal large repetitive regions, both of which contain a high percentage of glutamine and glutamic acid residues. This protein is a retinal-specific protein. Its exact length varies among individuals due to the presence of a 16aa repeat in the first C-terminal repetitive region. The 16aa repeat is encoded by the highly polymorphic 48-bp repeat, and 1-6 copies of the 16aa repeat have been identified in normal individuals. The current reference sequence shown here has a single copy of the 16aa repeat. This protein and the RP1 protein, another retinal-specific protein, play essential and synergistic roles in affecting photosensitivity and outer segment morphogenesis of rod photoreceptors. Mutations in this gene cause occult macular dystrophy (OMD). [provided by RefSeq, Sep 2010]
RP1L1 Gene-Disease associations (from GenCC):
- occult macular dystrophyInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Laboratory for Molecular Medicine
- retinitis pigmentosaInheritance: AD, AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
- retinitis pigmentosa 88Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- cone dystrophyInheritance: AR Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.537 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| C8orf74 | ENST00000304519.10 | c.242-6251T>G | intron_variant | Intron 2 of 3 | 1 | NM_001040032.2 | ENSP00000307129.5 | |||
| C8orf74 | ENST00000521818.1 | c.*417T>G | 3_prime_UTR_variant | Exon 3 of 3 | 5 | ENSP00000429505.1 | ||||
| RP1L1 | ENST00000329335.3 | n.231+20609A>C | intron_variant | Intron 1 of 2 | 2 | |||||
| C8orf74 | ENST00000523289.5 | n.*133+4077T>G | intron_variant | Intron 3 of 4 | 2 | ENSP00000430613.1 |
Frequencies
GnomAD3 genomes AF: 0.170 AC: 25804AN: 151998Hom.: 6366 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
25804
AN:
151998
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0937 AC: 2733AN: 29156Hom.: 594 Cov.: 0 AF XY: 0.0840 AC XY: 1294AN XY: 15404 show subpopulations
GnomAD4 exome
AF:
AC:
2733
AN:
29156
Hom.:
Cov.:
0
AF XY:
AC XY:
1294
AN XY:
15404
show subpopulations
African (AFR)
AF:
AC:
1662
AN:
2516
American (AMR)
AF:
AC:
291
AN:
3348
Ashkenazi Jewish (ASJ)
AF:
AC:
5
AN:
614
East Asian (EAS)
AF:
AC:
291
AN:
2324
South Asian (SAS)
AF:
AC:
265
AN:
3080
European-Finnish (FIN)
AF:
AC:
23
AN:
616
Middle Eastern (MID)
AF:
AC:
8
AN:
78
European-Non Finnish (NFE)
AF:
AC:
97
AN:
15254
Other (OTH)
AF:
AC:
91
AN:
1326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.576
Heterozygous variant carriers
0
64
129
193
258
322
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.170 AC: 25889AN: 152116Hom.: 6395 Cov.: 33 AF XY: 0.168 AC XY: 12486AN XY: 74382 show subpopulations
GnomAD4 genome
AF:
AC:
25889
AN:
152116
Hom.:
Cov.:
33
AF XY:
AC XY:
12486
AN XY:
74382
show subpopulations
African (AFR)
AF:
AC:
22485
AN:
41396
American (AMR)
AF:
AC:
1555
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
9
AN:
3472
East Asian (EAS)
AF:
AC:
570
AN:
5168
South Asian (SAS)
AF:
AC:
290
AN:
4824
European-Finnish (FIN)
AF:
AC:
386
AN:
10618
Middle Eastern (MID)
AF:
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
AC:
323
AN:
68020
Other (OTH)
AF:
AC:
259
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
708
1416
2123
2831
3539
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
210
420
630
840
1050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
415
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.